National Comprehensive Cancer Network



NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Subscribe to the NCCN Compendium
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN — Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines® & Clinical Resources

NCCN 3rd Annual Congress Hematologic Malignancies

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Congress Agenda

Satellite Symposia

Intended Audience

Accommodations

Registration Information

Accreditation

Commercial Support

Exhibiting

Refer a Friend

Go back to previous page

 

 

     
 

Commercial Support

This Congress is supported by educational grants:

  • Amgen
  • Bayer HealthCare Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Cephalon Oncology
  • Eisai Inc.
  • Genentech BioOnocology and Biogen Idec
  • Merck Oncology
  • Millennium Pharmaceuticals, Inc.
  • Novartis Oncology
  • Pharmion Corporation
  • sanofi-aventis, US

NCCN appreciates that these supporting companies recognize NCCN’s need for autonomy in the development of the content of NCCN programs and resources. All NCCN content is produced completely independently.

Last update 03/17/2008.

  
Quick Links





About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved